VolitionRx (VNRX) Insider Trading & Ownership $0.52 0.00 (-0.27%) As of 05/23/2025 04:10 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock VolitionRx (NYSEAMERICAN:VNRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.40%Number OfInsiders Buying(Last 3 Years)6Amount OfInsider Buying(Last 3 Years)$777,806.94Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$36,924.03 Get VNRX Insider Trade Alerts Want to know when executives and insiders are buying or selling VolitionRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VNRX Insider Buying and Selling by Quarter VolitionRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/16/2023Cameron John ReynoldsCEOBuy10,000$1.22$12,200.00 6/2/2023Salvatore Thomas ButeraCEOBuy10,000$1.59$15,900.00 2/22/2023Guy Archibald InnesDirectorBuy234,000$1.75$409,500.00 12/19/2022Jacob Vincent MicallefInsiderBuy25,000$2.30$57,500.00 12/19/2022Salvatore Thomas ButeraCEOBuy5,000$2.27$11,350.00 12/16/2022Jacob Vincent MicallefInsiderBuy7,339$1.96$14,384.44 12/16/2022Martin Charles FaulkesDirectorBuy55,000$2.10$115,500.00 12/12/2022Salvatore Thomas ButeraCEOBuy4,350$2.09$9,091.50 12/8/2022Nicholas PlummerInsiderBuy4,800$2.07$9,936.00 11/28/2022Salvatore Thomas ButeraCEOBuy5,000$2.21$11,050.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/19/2022Jacob Vincent MicallefInsiderBuy13,000$1.70$22,100.00 8/30/2022Cameron John ReynoldsCEOBuy3,500$1.61$5,635.00 8/26/2022Jacob Vincent MicallefInsiderBuy29,000$1.74$50,460.00 8/22/2022Salvatore Thomas ButeraCEOBuy5,000$1.64$8,200.00 8/2/2022Guy Archibald InnesDirectorBuy12,500$2.00$25,000.00 6/6/2022Jason Bradley Md TerrellInsiderSell14,949$2.47$36,924.03 (Data available from 1/1/2013 forward) VNRX Insider Trading Activity - Frequently Asked Questions Who is on VolitionRx's Insider Roster? The list of insiders at VolitionRx includes Cameron John Reynolds, Guy Archibald Innes, Jacob Vincent Micallef, Jason Bradley Md Terrell, Martin Charles Faulkes, Nicholas Plummer, and Salvatore Thomas Butera. Learn more on insiders at VNRX. What percentage of VolitionRx stock is owned by insiders? 15.40% of VolitionRx stock is owned by insiders. Learn more on VNRX's insider holdings. Which VolitionRx insiders have been buying company stock? The following insiders have purchased VNRX shares in the last 24 months: Cameron John Reynolds ($12,200.00), and Salvatore Thomas Butera ($15,900.00). How much insider buying is happening at VolitionRx? Insiders have purchased a total of 20,000 VNRX shares in the last 24 months for a total of $28,100.00 bought. VolitionRx Key ExecutivesDr. Martin Charles Faulkes Ph.D. (Age 80)Executive Chairman Compensation: $239.51kMr. Cameron Reynolds MBA (Age 53)Founder, CEO, President & Director Compensation: $572.43kDr. Gaetan Michel Ph.D. (Age 50)Chief Operating Officer Compensation: $518.15kDr. Salvatore Thomas Butera DVM (Age 72)Chief Executive Officer of Volition Veterinary Diagnostics Development LLC Compensation: $477.25kMr. Terig Hughes (Age 53)CFO & Treasurer Compensation: $338.74kDr. Jacob Vincent Micallef MBA (Age 68)Ph.D., Chief Scientific Officer Compensation: $571.55kMr. Nicholas Plummer (Age 53)Group General Counsel Ms. Louise Batchelor Day (Age 52)Group Chief Marketing & Communications Officer Mr. Thomas BygottSales & Marketing DirectorMr. Gael Forterre M.B.A. (Age 42)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Editas Medicine Insider Selling Lyell Immunopharma Insider Selling Larimar Therapeutics Insider Selling scPharmaceuticals Insider Selling Vigil Neuroscience Insider Selling Enanta Pharmaceuticals Insider Selling Fate Therapeutics Insider Selling Black Diamond Therapeutics Insider Selling Alector Insider Selling Lineage Cell Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NYSEAMERICAN:VNRX) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
